Biochemistry, Genetics and Molecular Biology
Beta Oxidation
82%
Enzyme
72%
Acyl-CoA
61%
Newborn Screening
58%
Blood Plasma
55%
Fibroblast
51%
Metabolic Pathway
49%
Peroxisome
47%
Oxidoreductase
42%
Adrenoleukodystrophy
42%
Familial Hypercholesterolemia
33%
Galactose
33%
Very Long Chain Fatty Acid
28%
Dehydrogenase
28%
Metabolite
27%
Lipid
24%
Biogenesis
23%
Inborn Error of Metabolism
22%
Genetic Disorder
22%
Pyridoxine
21%
Vitamin B6
21%
Intellectual Disability
21%
Very-Long-Chain Acyl-CoA Dehydrogenase
20%
Phenylketonuria
19%
Sanfilippo Syndrome
18%
Medicine and Dentistry
Familial Hypercholesterolemia
100%
Newborn Screening
42%
Inborn Error of Metabolism
33%
Low Density Lipoprotein Cholesterol
32%
Sanfilippo Syndrome
30%
Fabry Disease
26%
Enzyme Replacement Therapy
24%
Statin
24%
Mucopolysaccharidosis
23%
Hurler Syndrome
22%
Intima-Media Thickness
21%
Lysosomal Storage Disease
20%
Phenylketonuria
20%
Storage Disease
17%
Epileptic Seizure
15%
Pyridoxine-Dependent Epilepsy
15%
Atherosclerosis
15%
Pyridoxine
15%
Disease Course
14%
Genetic Screening
13%
Randomized Controlled Trial
13%
Oxidoreductase
12%
Genetic Disorder
12%
Hypercholesterolemia
12%
Galactosemia
11%
Keyphrases
Homozygous Familial Hypercholesterolemia (HoFH)
57%
L-carnitine
17%
Photosystem II
15%
Galactosemia
14%
Inherited Metabolic Diseases
12%
Peroxisomal Disorders
12%
Statins
11%
Medium-chain acyl-CoA Dehydrogenase Deficiency
10%
Inborn Errors of Metabolism
9%
Low-density Lipoprotein Cholesterol (LDL-C)
9%
Peroxisome
9%
Carotid Intima-media Thickness (cIMT)
9%
Peroxisomal
9%
Lipoproteins
9%
Enzyme Replacement Therapy
7%
Phenylketonuria
7%
Carnitine Deficiency
7%
Low-density Lipoprotein Cholesterol Level
7%
Lysosomal Storage Disease
6%
Fabry Disease
6%
Fibroblasts
6%
Statin Therapy
6%
Pyridoxine-dependent Epilepsy
6%
PDE-ALDH7A1
6%
Meta-analysis
6%